• Antibiotic Use
  • Triclosan Use Ban
  • Hospital Acquired Infections
  • Antimicrobial Resistance
  • The Science

Innovation Battling Disease and Infection


Posted by on Apr 5, 2011 in Uncategorized

CSA BioTech is an emerging biopharmaceutical company focused on commercializing a novel class of patented compounds known as ceragenins or CSAs. These compounds have broad-spectrum activity mimicking those of endogenous antimicrobial peptides such as LL-37. CSAs, however, are not peptides; rather synthetic small molecules that can be manufactured at large scale and are not subject […]